PMID- 33848212 OWN - NLM STAT- MEDLINE DCOM- 20210913 LR - 20210913 IS - 1535-4989 (Electronic) IS - 1044-1549 (Linking) VI - 65 IP - 2 DP - 2021 Aug TI - TREM2 Dictates Antibacterial Defense and Viability of Bone Marrow-derived Macrophages during Bacterial Infection. PG - 176-188 LID - 10.1165/rcmb.2020-0521OC [doi] AB - Macrophages undergo profound metabolic reprogramming to join key immunoregulatory functions, which can be initiated by pattern recognition receptors. TREM2 (triggering receptor expressed on myeloid cells 2), a macrophage phagocytic receptor, plays pivotal roles in sepsis by enhancing bacterial clearance, which is associated with regulation of reactive oxygen species (ROS) production. However, how intracellular ROS participate in TREM2-mediated bactericidal activity remains unclear. This study was designed to investigate the organelle source and biological activity of ROS in the context of TREM2-mediated immune defense during Escherichiacoli infection. Bone marrow-derived macrophages (BMDMs) were transfected with TREM2-overexpressing adenoviruses or control viruses and challenged with E. coli. The BMDMs were administered to mouse models with local E. coli infection. In addition, monocytic TREM2 expression, NOX2 concentrations, and pyroptosis were detected in patients with bacterial sepsis. General ROS production was found to be comparable between TREM2-overexpressing and control BMDMs upon E. coli challenge. The deficiency of Nox2 led to impaired phagosome degradation and lack of bactericidal ability and abolished TREM2-mediated protective activity against pulmonary E. coli infection. Overexpression of TREM2 suppressed mitochondrial ROS generation, inhibited NLRP3/caspase-1 inflammasome activation, and finally protected BMDMs from gasdermin D-mediated pyroptosis during pulmonary E. coli infection. The protective role of TREM2 was further confirmed in mice with abdominal E. coli infection. Moreover, monocytic TREM2 expression was positively correlated with NOX2 concentrations and negatively correlated with pyroptosis and disease severity in patients with bacterial sepsis. Collectively, TREM2 controls macrophage immune functions by fine-tuning ROS generation and enhances the host defense against bacterial infection. Our data suggest that TREM2 is a promising candidate target for sepsis therapy. FAU - Yang, ShiYue AU - Yang S AD - Department of Anesthesiology and Intensive Care, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; and. FAU - Yang, Yang AU - Yang Y AD - Department of Anesthesiology and Intensive Care, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; and. FAU - Wang, FeiFei AU - Wang F AD - Department of Anesthesiology and Intensive Care, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; and. FAU - Luo, QinYu AU - Luo Q AD - Department of Clinical Research Center, The Children's Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Child Health, Hangzhou, China. FAU - Zhang, Yan AU - Zhang Y AD - Department of Clinical Research Center, The Children's Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Child Health, Hangzhou, China. FAU - Zheng, Fei AU - Zheng F AD - Department of Clinical Research Center, The Children's Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Child Health, Hangzhou, China. FAU - Shu, Qiang AU - Shu Q AD - Department of Clinical Research Center, The Children's Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Child Health, Hangzhou, China. FAU - Chen, QiXing AU - Chen Q AD - Department of Clinical Research Center, The Children's Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Child Health, Hangzhou, China. FAU - Fang, XiangMing AU - Fang X AD - Department of Anesthesiology and Intensive Care, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; and. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Am J Respir Cell Mol Biol JT - American journal of respiratory cell and molecular biology JID - 8917225 RN - 0 (Membrane Glycoproteins) RN - 0 (Receptors, Immunologic) RN - 0 (Trem2 protein, mouse) RN - EC 1.6.3.- (Cybb protein, mouse) RN - EC 1.6.3.- (NADPH Oxidase 2) SB - IM MH - Animals MH - Bone Marrow Cells/*immunology/pathology MH - Escherichia coli/*immunology MH - Escherichia coli Infections/genetics/*immunology MH - Gene Expression Regulation/immunology MH - Macrophages/*immunology/pathology MH - Membrane Glycoproteins/genetics/*immunology MH - Mice MH - Mice, Knockout MH - NADPH Oxidase 2/genetics/immunology MH - Phagosomes/genetics/immunology MH - Pneumonia, Bacterial/genetics/*immunology/pathology MH - Receptors, Immunologic/genetics/*immunology OTO - NOTNLM OT - NOX2 OT - TREM2 OT - mitochondria OT - pyroptosis OT - sepsis EDAT- 2021/04/14 06:00 MHDA- 2021/09/14 06:00 CRDT- 2021/04/13 17:10 PHST- 2021/04/14 06:00 [pubmed] PHST- 2021/09/14 06:00 [medline] PHST- 2021/04/13 17:10 [entrez] AID - 10.1165/rcmb.2020-0521OC [doi] PST - ppublish SO - Am J Respir Cell Mol Biol. 2021 Aug;65(2):176-188. doi: 10.1165/rcmb.2020-0521OC.